Are Black Swans STILL COLLIDING with YOUR Supply Chain Do you remember where you were on Friday, March 13, 2020? I don’t think I will […]
4 Years Ago We Entered the Age of Continuous Disruption Read More »
FDA’S CALL FOR INDUSTRY COLLABORATION In a pivotal move towards advancing the quality and efficiency of pharmaceutical manufacturing, the Food and Drug Administration (FDA) has
Incentivizing Pharmaceutical Manufacturing Excellence Read More »
Axendia’s 2024 Life Sciences Industry Radar Axendia unveiled its fifth annual Life Science Industry Radar on February 15, 2024, during a live “Straight from the Source”
Plotting a Course to Success in the Age of Price Negotiations Read More »
Emerson Briefing Note Axendia was recently briefed by Kristel Biehler, VP of Life Sciences, and Bob Lenich, Business Director of Process and Knowledge Management at Emerson. The company
Accelerating Transfer with Standardized Recipe Management Read More »
Scitara Briefing Note Axendia was recently briefed by Jeff Mazzeo, Chief Marketing Officer at Scitara Corporation, as an update to our previous briefing in early 2023. Scitara, founded in
Enabling Lab Insights Through Data Mobility Read More »
FDA DIGITAL TRANSFORMATION SYMPOSIUM 2023 EVENT BRIEF “The future is already here- it’s just not evenly distributed,” declared William Gibson. Axendia published the “FDA’s e-Transformation
At FDA, The Future Is Already Here Read More »
Experts from IBM and Axendia shared the Journey to CSA in “Welcome to Wednesday” Maximo Event. FDA’s Computer Software Assurance (CSA) draft guidance is intended
Journey from Computer Software Validation (CSV) to Computer Software Assurance (CSA) Read More »
Propel Briefing Note Axendia was recently briefed by Chuck Serrin, VP Industry Marketing, Medical Devices & Life Sciences and Dario Ambrosini, Chief Marketing Officer, at
Does MedTech Need Product Value Management? Read More »
Experts from AstraZeneca, Axendia and Tulip Interfaces shared how to move beyond a traditional validation approach and its reliance on non-value-added documentation to unblock your
2023 Veeva R&D and Quality Summit Event Brief Axendia covered the 2023 Veeva R&D and Quality Summit in Boston on Sept. 13 and 14. The
Veeva Extends Life Science Industry Cloud into Manufacturing Read More »
The FDA has taken another step towards realizing their vision for encouraging pharmaceutical quality management practices. FDA’s Center for Drug Evaluation and Research (CDER) has developed
FDA Encourages Industry to Achieve Quality Management Maturity (QMM) Read More »
QbDVision® Briefing Note Axendia was recently briefed by the executive team at QbDVision® on its unified digital Chemistry, Manufacturing and Controls (CMC) platform. “Our focus is on breaking
Accelerating Time to Market with Digital Tech Transfer Read More »
